Phase I trial of avibactam/ceftaroline fosamil
Latest Information Update: 04 Feb 2008
At a glance
- Drugs Avibactam/ceftaroline fosamil (Primary)
- Indications Community-acquired pneumonia; Gram-negative infections; Gram-positive infections; Skin and soft tissue infections
- Focus Adverse reactions
- Sponsors Forest Laboratories
- 04 Feb 2008 New trial record.